William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Downgrades Global Eagle Entertainment (ENT) to Underperform
-
Ceridian Announces Upsizing and Pricing of Secondary Public Offering
-
Becton Dickinson (BDX) Reaction To FDA Letter Is Overblown - William Blair
-
Frontdoor, Inc. (FTDR) Announces Proposed 16.734M Secondary Offering
-
Frontdoor Announces Launch of Secondary Equity Offering of Remaining Shares of Common Stock Held by ServiceMaster
-
William Blair Reiterates Market Perform Rating on Embraer SA (ERJ)
-
UPDATE: William Blair Upgrades DENTSPLY International (XRAY) to Outperform
-
Cushman & Wakefield plc (CWK) Announces Proposed 16.5M Share Offering by Selling Shareholders, TPG GLobal LLC & Ontario Teachers' Pension Plan
-
Cushman & Wakefield Announces Commencement of Public Offering by Selling Shareholders
-
William Blair Downgrades Restoration Robotics (HAIR) to Market Perform
-
Ceridian (CDAY) Launches 11M Share Secondary Public Offering
-
Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
-
William Blair Starts Cellectis (CLLS) at Outperform
-
William Blair Starts CRISPR Therapeutics (CRSP) at Market Perform
-
William Blair Starts Allogene (ALLO) at Outperform
-
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
-
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
-
CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
-
Acer Therapeutics to Participate in Upcoming Investor Conferences
-
William Blair Downgrades Sientra (SIEN) to Market Perform
-
Switch Announces Fourth Quarter and Full Year 2018 Financial Results
-
Pan-African e-Commerce Platform Jumai Files U.S. IPO
-
F5 Networks (FFIV) NGINX Acquisition Is A Bold Bet On DevOps - William Blair
-
Pfenex Inc. (PFNX) On Track To Operating Profitability - William Blair
-
William Blair Launches Three New Funds
-
ShotSpotter to Participate at the William Blair Technology Conference on March 13 and the 31st Annual ROTH Capital Conference on March 18-19
-
Girls Who Invest Celebrates International Women’s Day
-
CORRECTING and REPLACING Girls Who Invest Celebrates International Women’s Day
-
EverQuote to Participate at Upcoming March Investor Conferences
-
EverQuote to Participate at Upcoming March Investor Conferences
-
Form D/A William Blair Emerging
-
William Blair Starts U.S. Physical Therapy (USPH) at Outperform
-
William Blair Downgrades Spark Therapeutics (ONCE) to Market Perform Following Takeout Bid by Roche
-
Atara Biotherapeutics to Participate in Upcoming Conferences
-
Atara Biotherapeutics to Participate in Upcoming Conferences
-
Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update
-
Wiliam Blair Finds The General Electric (GE) Silver Lining
-
William Blair Starts Haymaker Acquisition Corp. (HYAC) at Outperform
-
Tufin Files Registration Statement for Proposed Initial Public Offering
-
Form D/A William Blair Systematic
-
Carisma Therapeutics Announces Upcoming Conference Participation
-
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in March
-
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in March
-
William Blair Increases Its Transportation, Logistics, and Automotive Teams; Expands Its Charlotte, NC Footprint
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
Form SC 13G/A UNIVERSAL ELECTRONICS Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31
-
GTT to Participate in March 2019 Conferences
-
Tmunity Announces Participation at Four Upcoming Investor Conferences
-
Form X-17A-5 WILLIAM BLAIR & COMPANY For: Dec 31

